首页|肺癌患者放化疗后并发肺部感染的影响因素研究

肺癌患者放化疗后并发肺部感染的影响因素研究

扫码查看
目的:分析肺癌患者放化疗后并发肺部感染的影响因素.方法:回顾性分析2020年3月—2022年3月广东省农垦中心医院收治的符合放化疗指征的100例肺癌患者的临床资料,统计其放化疗后肺部感染发生情况及病原菌分布情况,并根据其有无发生肺部感染将其分为A组(发生肺部感染)和B组(未发生肺部感染),同时分析可能会影响其发生肺部感染的影响因素.结果:100例肺癌患者放化疗后有21例(21.00%)患者发生肺部感染.21例发生肺部感染的患者中,病原菌分布最多的为葡萄球菌属,占42.86%;肺炎克雷伯菌占28.57%;假单胞菌属占19.05%;真菌占9.52%.两组患者在性别及吸烟史方面比较,差异无统计学意义(x2=0.004、1.584,P>0.05);A组患者在年龄方面与B组患者比较,差异有统计学意义(x2=8.765,P<0.05);A组患者在放化疗时间方面与B组患者比较,差异有统计学意义(x2=7.864,P<0.05);A组患者在化疗药物方面与B组患者比较,差异有统计学意义(x2=8.765,P<0.05);A组患者在白蛋白含量方面与B组患者比较,差异有统计学意义(x2=4.571,P<0.05);A组患者在Karnofsky功能状态评分标准(KPS)评分方面与B组患者比较,差异有统计学意义(x2=5.314,P<0.05).影响患者化疗后并发肺部感染的独立危险因素分别为年龄>55岁、放化疗时间>2周、联合化疗药物、白蛋白含量≤30 g/L及KPS评分≤80分.结论:肺癌患者放化疗治疗结束后,存在并发肺部感染的风险,病原菌以葡萄球菌属较为常见,影响患者放化疗后并发肺部感染的独立危险因素分别为年龄>55岁、放化疗时间>2周、联合化疗药物、白蛋白含量≤30 g/L及KPS评分≤80分,临床需要根据其影响因素及时采取干预措施,并且根据病原菌分布情况合理选择抗感染药物,以进一步提高患者肺部感染防治效果.
Study of Factors Affecting Lung Infections Complicated by Radiotherapy in Lung Cancer Patients
Objective:To analyze the influencing factors of lung infections complicating lung cancer patients after radiotherapy.Methods:The clinical data of 100 lung cancer patients admitted to the hospital from March 2020 to March 2022 who met the indi-cations of radiotherapy were retrospectively analyzed,and the occurrence of lung infections after radiotherapy and the distribution of pathogenic bacteria were counted.They were categorized into Group A(lung infection occurred)and Group B(no lung infection occurred)based on whether they had or had not developed a lung infection.The influencing factors that may affect the occurrence of lung infection were also analyzed.Results:A total of 21 patients(21.00%)of 100 lung cancer patients developed lung infections after radiotherapy.Among the 21 patients who developed lung infections,the pathogenic organisms with the highest distribution were Staphylococcus spp.(42.86%),followed by Klebsiella pneumoniae(28.57%),Pseudomonas spp.(19.05%),and fungi(9.52%),respectively.There was no statistically significant difference between the two groups in terms of gender and smoking history(x2= 0.004,1.584,P>0.05).There was a statistically significant difference in terms of age between group A and group B(x2=8.765,P<0.05).The difference was statistically significant when comparing the duration of radiotherapy between group A and group B(x2= 7.864,P<0.05).The difference was statistically significant when comparing the chemotherapeutic drugs between group A and group B(x2=8.765,P<0.05).There was a statistically significant difference between group A in terms of albumin content when compared to group B(x2=4.571,P<0.05).There was a statistically significant difference between group A in terms of KPS score when compared to group B(x2=5.314,P<0.05).The independent risk factors affecting the complication of lung infection after che-motherapy in patients were age>55 years,duration of radiotherapy>2 weeks,combination of chemotherapeutic agents,albumin level≤30 g/L,and KPS score≤80 points points,respectively.Conclusion:Lung cancer patients are at risk of complicating lung infections at the end of radiotherapy treatment,and the pathogenic bacteria are more common in Staphylococcus spp.The indepen-dent risk factors affecting the complication of lung infection after radiotherapy are age>55 years,radiotherapy time>2 weeks,combined chemotherapy drugs,albumin content≤30 g/L and KPS score≤80 points.Clinical intervention measures should be taken in time according to the influencing factors,and anti-infective drugs should be rationally selected according to the distribution of pathogenic bacteria to further improve the prevention and treatment of lung infection.

Lung cancerRadiotherapy and chemotherapyPulmonary infectionInfluencing factorsPathogenic bacteria

周素丽

展开 >

广东省农垦中心医院肿瘤内科五区,广东 湛江 524000

肺癌 放化疗 肺部感染 影响因素 病原菌

2024

黑龙江医学
中华医学会黑龙江分会

黑龙江医学

影响因子:0.714
ISSN:1004-5775
年,卷(期):2024.48(5)
  • 13